Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients with advanced pancreatic cancer

@article{Ikemoto2013ChangesOI,
  title={Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients with advanced pancreatic cancer},
  author={T. Ikemoto and M. Shimada and S. Iwahashi and Y. Saito and Mami Kanamoto and H. Mori and Y. Morine and S. Imura and T. Utsunomiya},
  journal={International Journal of Clinical Oncology},
  year={2013},
  volume={19},
  pages={81-86}
}
  • T. Ikemoto, M. Shimada, +6 authors T. Utsunomiya
  • Published 2013
  • Medicine
  • International Journal of Clinical Oncology
  • BackgroundThe prognosis of pancreatic cancer is extremely poor regardless of various combination therapies. Immunoaugumentation against tumor cells was recently A focus. We reported that the population of Foxp3+CD25+CD4+ regulatory T cells (Foxp3+Treg) was the new parameter for the estimation of host immunity and had correlation with tumor aggressiveness. Here we show the immunoaugumentation effects of Japanese Kampo medicine, Juzen-Taihoto/TJ-48, empirically considered as an… CONTINUE READING
    17 Citations

    Figures, Tables, and Topics from this paper.

    Role of Kampo Medicine in Integrative Cancer Therapy
    • 19
    • PDF
    An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics.
    • 87
    • PDF
    Molecular Targeted Intervention for Pancreatic Cancer
    • 22
    • PDF

    References

    SHOWING 1-10 OF 36 REFERENCES
    Clinical Roles of Increased Populations of Foxp3+CD4+ T Cells in Peripheral Blood from Advanced Pancreatic Cancer Patients
    • 80
    Japanese herbal medicine TJ-48 prevents autoimmune diabetes in NOD mice.
    • 8
    IL-12 and IL-18 Induction and Subsequent NKT Activation Effects of the Japanese Botanical Medicine Juzentaihoto
    • 17
    • PDF
    FOXP3+ regulatory T cells as biomarkers in human malignancies
    • 13
    FOXP3+ regulatory T cells as biomarkers in human malignancies.
    • 18